This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
A New Model for the Pharmaceutical Industry: The Institute of OneWorld Health
Schoen, Oliver; Mair, JohannaCase DG-1480-EEntrepreneurship, Innovation and ChangeThis case introduces the Institute of OneWorld Health, a company dedicated to producing drugs for neglected diseases and the first non-profit pharmaceutical company in the world. Founded in 2000 by Dr. Victoria Hale, IOWH took expired and donated patent compounds and developed them through all the stages of clinical testing and approval into drugs to fight the world's most destructive diseases, usually occurring in Third World countries where per...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS) - Teaching Note: Aligning stakeholders in the biotech industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacTeaching Note SMT-136-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €0.00
-
The Freeplay Energy Group and Foundation (B)
Ganly, Kate; Mair, JohannaCase DG-1501-EBusiness Ethics and Corporate Social Responsibility, Innovation and Change, StrategyCase B updates the original by two additional years. In this time the Freeplay Group undertakes an IPO, listing on the UK stock exchange as Freeplay Energy plc. The Freeplay Foundation continues to receive support from the new public company and expands its projects to bring communication and energy to the most "underdeveloped" areas of Africa but must also look elsewhere for support and funding. Freeplay Energy also undertakes significant expans...Starting at €5.74